| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| DSP Nifty Healthcare Index Fund (G) Direct |
| [Equity: Index] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
-0.23 |
| Equity |
99.75 |
| Trep |
0.48 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
50.35% |
| Top 10 Holdings |
77.02% |
| Top 25 Holdings |
100.00% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
77.95 |
| Healthcare |
21.8 |
| Cash |
0.25 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
5.32 |
| PE Ratio |
37.92 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Sun Pharmaceutical Industries Limited |
18.32 |
| DIVI LABORATORIES LTD. |
8.11 |
| Max Healthcare Institute Limited |
8.09 |
| Apollo Hospitals Enterprise Limited |
8.02 |
| Dr Reddys Laboratories Limited |
7.81 |
| Cipla Limited |
7.55 |
| Lupin Limited |
5.56 |
| Fortis Health Care Ltd |
4.89 |
| Torrent Pharmaceuticals Limited |
4.51 |
| Laurus Labs Limited |
4.16 |
| Aurobindo Pharma Limited |
3.40 |
| Alkem Laboratories Limited |
3.28 |
| Glenmark Pharmaceuticals Limited |
3.20 |
| Biocon Limited |
2.77 |
| Mankind Pharma Limited |
2.53 |
| Zydus Lifesciences Limited |
2.30 |
| IPCA Laboratories Limited |
2.12 |
| Abbott India Limited |
1.37 |
| Piramal Pharma Limited |
0.96 |
| Syngene International Limited |
0.80 |
| TREPS / Reverse Repo Investments |
0.48 |
| Net Receivables/Payables |
-0.23 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
